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Abstract 
 
Convergence processes are based on the activity of distinct industry sectors showing cross-
industry collaborations. The aim of this paper is to analyze cross-industry collaborations between 
the food and pharmaceutical sectors in the convergence area of functional foods. Selected 
companies from food (Nestlé/Danone) and pharmaceutical (Martek/Bayer HealthCare) sectors 
are analyzed using the determinants of motivation and industrial scope. The analysis shows that 
food companies are more active in cross-industry collaborations than pharmaceutical companies. 
The latter are more active at the front-end of the value chain focusing on research and 
development, and delivering their ingredients to food companies that due to their higher 
expertise in consumer marketing launch the products. While the first cross-industry 
collaborations were based on an exploration motivation, those that follow focus on exploitation. 
Acquisitions and licensing agreements are dominant in inside-out and outside-in processes, 
whereas strategic alliances and joint ventures are based on a coupled process between the food 
and pharmaceutical sectors. 
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Introduction 
 
The market for foods and food ingredients has changed rapidly in recent years (Siró et al. 2008). 
There is a growing interest among consumers in so-called functional foods, including ingredients 
that may alleviate the symptoms of ageing and illness (Gray, Armstrong, and Farley 2003; Siró 
et al. 2008). Most new product launches in the functional food sector deliver new products; this 
is in contrast to the established food market, where most new products are only variations of 
existing products (Mark-Herbert 2004). Consequently, competences from different industries 
(i.e. food and pharmaceutics) are required for the innovation process. Indeed, there is evidence 
that firms of various industrial backgrounds are active on the functional food market (Curran, 
Bröring, and Leker 2010; Bröring 2005; Bornkessel, Bröring, and Omta 2014; Boehlje, Roucan-
Kane, and Bröring 2011). 
 
Recent literature focuses on innovations across industrial boundaries. The concept of cross-
industry innovation is defined as the creative imitation and retranslation of existing solutions 
from one industry segment to another (Enkel and Gassmann 2010; Gassmann, Daiber, and Enkel 
2011; Hahn 2015). Furthermore, the emergence of a new industry segment consisting of firms 
formerly active in different industries, leading to a blurring of boundaries between the industries 
is called industry convergence (Hacklin 2008; Bröring 2005). Both concepts are discussed as a 
process rather than a steady state (e.g. Curran, Bröring, and Leker 2010; Hacklin 2008; 
Gassmann and Sutter 2013). Extant literature addresses the front end of science and technology 
convergence using scientific publications and patent documents (e.g. Curran, Bröring, and Leker 
2010). However, literature regarding the assessment of market and industry convergence using 
cross-industry collaborations is limited, especially in the emerging area at the borderline of foods 
and drugs leading to functional foods.  
 
The overall aim of this paper is to analyze cross-industry collaborations in convergence leading 
to the functional food sector. In doing so, the determinants of cross-industry collaborations are 
analyzed regarding the motivation and industrial scope of each identified collaboration. Using a 
longitudinal case study approach, this study focuses on the emerging area at the borderline of 
foods and drugs, where new product-market combinations such as functional foods or dietary 
supplements arise. The goal is to identify differences between the companies stemming from the 
food and pharmaceutical sectors in the employment of cross-industry collaborations.  
 
The remainder of this paper is structured as follows. Section 2 focuses on cross-industry 
collaborations in convergence. In doing so, the resource-based view is employed to derive the 
underlying dynamics of the cross-industry collaborations using the two determinants of 
motivation and industrial scope of the collaboration. Section 3 presents the sample and methods 
of the study. In section 4, the four case studies focusing on the emerging area of functional foods 
are presented; the section then concludes with a cross-case comparison. Finally, the findings of 
the study and their implications for academics and practitioners are discussed, before the paper 
concludes with an outlook on future research possibilities. 
 
Theoretical Background 
 
Cross-Industry Collaborations in Convergence  
 
Numerous recent literature sources discuss the phenomenon of innovation across industry 
borders (Enkel and Gassmann 2010; Gassmann, Daiber, and Enkel 2011; Gassmann, Enkel, and 
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Chesbrough 2010). General concepts such as open innovation or the innovation value chain can 
be discussed either within a special industrial sector or across different sectors. The horizontal 
innovation across industry boundaries is still a challenge to manage, both in literature and in 
practice (Hahn 2015; Gassmann, Enkel, and Chesbrough 2010). Especially in the rapidly 
growing functional food market, active companies have to cope with technology, market and 
regulatory challenges (Bröring 2005; Wong, Lai, and Chan 2015). Multifaceted definitions of 
convergence can be found in the literature. Recent studies provide a comprehensive overview of 
these definitions and their different emphases (Bröring 2005; Hacklin 2008; Curran 2010; 
Preschitschek 2014), mainly following the common idea summarised by the Organization for 
Economic Co-operation and Development: “the blurring of technical and regulatory boundaries 
between sectors of the economy”(OECD 1992). 
 
Regarding the process perspective on convergence, one approach is the description of the 
consecutive steps – science, technology, market and industry – as an idealised time series of 
events leading to a complete convergence of two hitherto distinct industrial sectors (Curran, 
Bröring, and Leker 2010; Hacklin 2008). The initial step implies that distinct scientific 
disciplines begin to cite each other in interaction with first collaborations of scientific disciplines. 
For instance, the food domain cites pharmaceutical research results in studies on functional 
foods. Decreasing the distance between applied sciences and the technological development of 
different areas is defined as the second step. The subsequent arising of new product-market 
combinations such as functional foods or dietary supplements is called market convergence. The 
final step of industry convergence 0F
1
 incorporates fusion of firms or industry segments (Curran, 
Bröring, and Leker 2010; Hacklin 2008). While the front end of the convergence process 
encompassing science and technology convergence is scrutinised in many recent studies using 
bibliometric data (Curran 2010; Preschitschek 2014), literature on the evaluation of the 
consecutive steps of market and industry convergence is scarce.  
 
Literature on convergence defines market convergence as product-market combinations focusing 
on consumer products that combine functions and technologies of products from different 
industry sectors (Curran, Bröring, and Leker 2010; Bröring 2005; Pennings and Puranam 2001; 
Stieglitz 2004; Katz 1996). This definition focuses mainly on the demand side of the market, 
whereas first measurement approaches of market convergence primarily focus on the supply side 
using collaborations of companies from different industrial backgrounds (Sick et al. 2015; 
Preschitschek 2014). These measures of market convergence can be specified as cross-industry 
collaborations. With respect to the consecutive steps of convergence processes, the analysis of 
cross-industry collaborations seems to deliver the unifying element to analyze the junction 
between market and industry convergence. This analysis covers parts of both stages as cross-
industry collaborations may provide a measure for the combination of functions and technologies 
of products from different industry sectors (market convergence) as well as the fusion of firms or 
industry segments (industry convergence). Thus, the present study focuses on the later stages of 
convergence, encompassing market and industry convergence.  
 
                                                          
1
 Most literature sources (e.g. Preschitschek et al. 2013; Kim et al. 2015; Bröring, Cloutier, and Leker 2006) use the 
term ‘industry convergence’ for the last phase as well as for the whole phenomenon as the last step is concurrently 
the result of the process. In this study, the term ‘convergence’ is used for the whole process and ‘industry 
convergence’ for the last phase of the convergence process. 
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The emergent market during convergence implies a vulnerable strategic position of the involved 
companies due to the difficult market situation of competitors stemming from different industry 
sectors. In the context of the resource-based view (RBV, originated in Penrose 1959), this 
vulnerable strategic position triggers companies to join collaborations in order to gain critical 
resources and competences that enable companies to share costs and risks (Eisenhardt and 
Schoonhoven 1996; Das and Teng 2000; Parmigiani and Rivera-Santos 2011). As resources and 
competences differ between industry sectors (Penrose 1959), these are complementary (Das and 
Teng 2000). This might lead to competence gaps as the involved companies have to stretch their 
resources to serve the adjacent industry (Pennings and Puranam 2001). In order to save scarce 
resources, the cross-industry collaborations may show a high level of competence 
complementarity to take advantage of the distinct core competences (Batterink 2009; Garbade 
2014; Liu et al. 2014). In analysing convergence, recent literature uses strategic alliances, joint 
ventures, and mergers and acquisitions to operationalise market convergence (Preschitschek 
2014; Sick et al. 2015). In addition, licensing agreements are discussed in the context of 
convergence processes (Bornkessel, Bröring, and Omta 2014).  
 
Licensing agreements encompass the contract between two companies about selling the rights to 
use resources and competences against payment of a licensing fee (Gallini and Winter 1985). 
The licensor possesses resources and competences, such as inventions or designs, that the 
licensee lacks (Parmigiani and Rivera-Santos 2011). Various definitions of strategic alliances 
can be found in the extant literature about the phenomenon of collaborations between different 
partners. As the broad definition leads to an overlapping of the meaning of strategic alliances 
with other collaboration forms, this study concentrates on a narrower perspective and defines 
strategic alliances as follows: formal agreements between two partners, which key attribute is to 
exist for a set time and task (Parmigiani and Rivera-Santos 2011). In the context of the RBV, 
strategic alliances are used if resources and competences for the development are owned by 
different companies and cannot be separated from the involved companies (Madhok 1997; Das 
and Teng 2000). Thus, strategic alliances deliver platforms of learning whereas the transfer of 
resources and competences is intricate (Parmigiani and Rivera-Santos 2011). The collaboration 
type of a joint venture is defined as the creation of a jointly-owned entity by two companies that 
stay separate, resulting in risks and rewards for each company (Parmigiani and Rivera-Santos 
2011; Contractor and Lorange 2002). Regarding the RBV, the used resources and competences 
of the two companies merge in a joint venture. Based on the definition of mergers and 
acquisitions encompassing the fusion of companies (Hennart and Reddy 1997), the resources and 
the competences of the involved companies completely merge.  
 
Determinants of Cross-Industry Collaborations in Convergence 
 
Two main determinants can be used to analyze collaborations in convergence: the motivation 
and the industrial scope of the collaboration. 1F
2
 
 
Overall, companies join alliances to gain a competitive advantage (e.g. Lavie 2006). Beside this 
general aim, the exploration and exploitation model of organizational learning (based on March 
1991) can be applied to analyze different collaboration forms based on the underlying motives 
and thus to identify the motivation of a collaboration. On the one hand, exploration 
                                                          
2
 Please refer to (Appendix) Table A1 for an overview of the used terminology. 
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collaborations aim to explore new opportunities while, on the other hand, exploitation 
collaborations aim to execute existing knowledge (March 1991; Koza and Lewin 1998; 
Rothaermel and Deeds 2004). Thus exploration collaborations focus on longer-term competitive 
advantage, whereas exploitation collaborations concentrate on short-term commercialization. 
The two traits focus of collaboration and type of interdependency based on the framework 
introduced by Parmigiani & Rivera-Santos (Parmigiani and Rivera-Santos 2011) can be used in 
order to analyze whether the cross-industry collaborations are of an exploration or exploitation 
nature. First, the focus of collaboration relies on the general distinction between gathering new 
knowledge and relying on existing knowledge. While exploration collaborations aim to create 
new knowledge, exploitation collaborations aim to execute existing knowledge (Rothaermel and 
Deeds 2004; Parmigiani and Rivera-Santos 2011; March 1991). Thus a collaboration focusing on 
exploration is characterised by extensive research with the aim of making new discoveries, while 
an exploitation collaboration utilises existing resources and competences (Rothaermel and Deeds 
2004). The second trait is the type of interdependence in collaborations, which focuses on the 
intensity of cooperation. While the exploration collaboration encompasses a joint development 
using resources and competences from both partners (reciprocal interdependence), the 
exploitation collaboration shows a discrete interdependence with decisions made independently 
by the partners (Parmigiani and Rivera-Santos 2011).  
 
The second determinant of industrial scope of the collaboration focuses on the involvement of 
different industry sectors. In the context of convergence with partners from different industrial 
backgrounds, the collaboration may encompass either resources and competences from one 
industry sector or from both involved industry sectors (Boehlje and Bröring 2011). While 
opening up across industrial borders, the distinction between three process forms (based on open 
innovation approach, ref. e.g. Enkel, Gassmann, and Chesbrough 2009) can be made: the 
outside-in (ref. to Ng 2011, for an application in the agricultural sector), inside-out and coupled 
processes. Relating the general approach to converging industries, the outside-in process 
encompasses the integration of resources and competences from other industry sectors (e.g. a 
company being a licensee) while the inside-out process focuses on the externalization of assets 
towards other industry sectors (e.g. a company being a licensor). The coupled process 
incorporates both the internalization of external assets as well as the externalization of internal 
assets. This leads to the following four categories to consider in analysing the industrial scope of 
the collaboration: (a) within the same industry or (b) following an outside-in or (c) inside-out or 
(d) coupled process across industrial borders.  
 
Beyond this theoretical background, the study at hand aims to deliver a framework with which to 
assess convergence based on cross-industry collaborations in the emerging area of functional 
foods. This leads to the following research question: 
 
RQ: What kinds of cross-industry collaborations can be used to close competence gaps in 
convergence between food and drugs? 
 
Research Framework 
 
Although literature about the evaluation of market and industry convergence is limited, a case 
study on market convergence in the biofuel sector (Preschitschek 2014) and one in the field of 
stationary energy storage systems (Sick et al. 2015) were recently published. There is also little 
literature on the emerging sector of functional foods. The convergence process is considered to 
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be either substitutive (leading to industry fusion) or complementary (leading to a new value 
chain between the old ones) (e.g. Bröring and Cloutier 2008). The convergence process of 
functional foods emerging between foods and drugs is already defined as complementary in the 
literature (Bröring and Cloutier 2008). Therefore, the study at hand concentrates on the 
complementary convergence process in which a new value chain arises between the food and 
pharmaceutical sectors, delivering borderline products such as functional foods. 
 
To analyze the arisen inter-industry segment, the study at hand focuses on companies that 
originate from either the food or the pharmaceutical sectors. After identifying their general 
activity in licensing agreements, strategic alliances, joint ventures, and mergers and acquisitions, 
the study identifies and describes cross-industry collaborations focusing on the emerging inter-
industry segment over the last ten years. The aim is to depict the emergence of the inter-industry 
segment between the food and pharmaceutical sectors (Figure 1). In addition, the relevant 
collaborations are analyzed using the two above-described determinants of motivation and 
industrial scope of collaboration. 
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Figure 1. Emergence of inter-industry segment based on the cross-industry collaborations during 
convergence 
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Methods 
 
Following an exploratory approach, the study at hand aims to answer the research question by 
employing a longitudinal case study focusing on the functional food sector. The case study 
approach is a research strategy that uses one or more cases, for instance to create theoretical 
constructs (Eisenhardt 1989; Eisenhardt and Graebner 2007). Based on different data sources, 
case studies contain extensive empirical descriptions of specific instances of a phenomenon 
(Eisenhardt and Graebner 2007; Yin 1997).  
 
In order to analyze cross-industry collaborations in the convergence of the food and 
pharmaceutical sectors leading to borderline products such as functional foods and dietary 
supplements, two leading companies of each sector were selected based on market reports, 
websites focusing on this industry segment (e.g. http://www.nutraingredients.com), and scientific 
literature about functional foods (e.g. Bigliardi and Galati 2013; Siró et al. 2008), as well as 
further desk research. Sector leading companies are chosen as these are expected to show 
activities in the emerging inter-industry segment. In this way, the leading position was identified 
based on sales and market significance. The selected companies are Nestlé and Danone as 
representatives for the food sector and Martek and Bayer HealthCare for the pharmaceutical 
sector. 
 
Following a quantitative approach using publicly available data, strategies to close competence 
gaps were analyzed from four angles: first, mergers and acquisitions; second, licensing 
agreements; third, strategic alliances; and fourth, joint ventures. The identified cooperating 
companies were scrutinised with regard to their industrial background. The industrial 
background of the manufacturers was categorised according to Standard Industrial Classification 
(SIC) codes (U.S. Securities and Exchange Commission 2011) available in the company profiles 
of the Nexis database. Based on SIC codes, the level of complementarity between the involved 
partners is discussed in the following results part. Cross-industry activities focusing on the 
emerging inter-industry segment are those in which the collaborating partners stem from 
different industrial backgrounds. Firstly, mergers and acquisitions were analyzed using the 
search mask ‘mergers and acquisitions’ of Nexis using each company as search term. This 
search mask refers to the Mergerstat M&A database, which provides detailed information on 
over 30 years’ worth of publicly announced mergers, acquisitions and divestitures (Nexis 2014).  
 
Secondly, using the search mask ‘firm’ the identified companies were analyzed considering their 
licensing agreements, strategic alliances and joint ventures using each company as search term. 
The time frame was restricted to the period from September 2005 to August 2015, covering the 
last 10 years as ten years show an appropriate time frame to  industry developments. In addition, 
this time frame is characterised by an increasing importance of the functional food sector (Siró et 
al. 2008; Wong, Lai, and Chan 2015).  
 
The identified cross-industry collaborations that target the emerging inter-industry segment 
between the food and pharmaceutical industries were analyzed according to the collaboration 
determinants of motivation and industrial scope based on the information given in the reports. 
The identified collaborations were analyzed with regard to their motivation (exploration vs. 
exploitation) by using the two measures of focus of collaboration (new knowledge vs. existing 
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knowledge) and type of interdependency (reciprocal vs. discrete). In doing so, the collaborations 
were analyzed with regard to their aim of either focusing on the generation of new knowledge, 
for example research on new functional ingredients, or focusing on the utilization of already 
existing knowledge, thus using already explored functional ingredients in the existing product 
portfolio. In addition, the relationship of the two partners was analyzed to distinguish between 
joint efforts to reach the aim (reciprocal), for instance a joint department to research a new 
functional ingredient; or the sole incorporation of resources and competences managed by one 
company (discrete), for instance using external research results in the context of the internal 
development process. The industrial scope was first identified based on the industrial 
background of the involved partners (SIC code). Second, if the companies stemmed from 
different industrial backgrounds, the direction of knowledge exchange across industrial borders 
(outside-in, inside-out, coupled) was determined. In the case of mergers and acquisitions, and 
licensing agreements, the position was considered: e.g. being a licensor shows an inside-out 
process and in contrast being a licensee shows an outside-in process. For joint ventures and 
strategic alliances, the specific agreements about knowledge exchange were considered. This 
categorization scheme was applied to the evaluation of the in-depth descriptions of the 
considered collaborations.  
 
Results 
 
Emerging Inter-Industry Segment 
 
The considered companies are active in cross-industry collaborations with different degrees of 
intensity. Most of the collaborations focusing on the emerging inter-industry segment of 
functional foods are across industrial borders, thus the collaborating partners stem from different 
industrial backgrounds. The results show that only acquisitions can be identified in the category 
of mergers and acquisitions focusing on the inter-industry segment of functional foods. While the 
two food companies (Nestlé and Danone) focus on acquisitions within and outside their native 
sector, the two pharmaceutical companies (Martek Biosciences Corporation and Bayer 
HealthCare) put the emphasis on licensing agreements (Figure B1, see Appendix B). In the 
following part describing the four cases, only those collaborations are considered and described 
in depth, focusing on the inter-industry segment of functional foods.  
 
Cross-industry Collaborations in the Food Sector 
 
Case 1. Nestlé 
 
The company Nestlé was founded in 1866 in Switzerland and has gained a worldwide 
significance in the food market, operating in eighty-six countries. While the origin of the 
company lies in food products, in recent years Nestlé’s strategy has focused on a reorientation 
towards health and wellbeing, which can be also shown in the SIC categorization including the 
food sector (codes beginning with 20) as well as the assignment of pharmaceutical preparations 
(SIC 2834). Nestlé’s product portfolio covers a wide range of consumer food products, which are 
mostly marketed via brands. Key products include baby food, bottled water, cereals, chocolate, 
coffee, dairy products, and chilled and frozen foods. The company also shows activity in more 
specialised offerings, including weight management products and healthcare nutrition. 
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Furthermore, Nestlé’s healthcare nutrition portfolio ranges from supplements for athletic healthy 
persons to nutritional formulas for the recovery of patients. This product portfolio shows a high 
diversification in borderline products in the inter-industry segment between food and 
pharmaceutics. 
 
Chronological Development 
Overall, the amount of cross-industry collaborations focusing on the inter-industry segment of 
functional foods increased during the last 10 years (Figure 2).  
Figure 2. Chronological development of Nestlé's cross-industry collaborations focusing on the 
inter-industry segment of functional foods in the last ten years. 
 
The three licensing agreements that focus on the inter-industry segment of functional foods are 
between partners stemming from different industrial backgrounds. In two of three licensing 
agreements, Nestlé is in the licensor position, thus showing an inside-out process. In 2013, 
Aspen Pharmacare acquired licenses for several of Nestlé’s products. In the same year, Opsona 
Therapeutics entered into a licensing agreement for a novel pre-clinical soluble protein. 
Furthermore, Nestlé uses a certain probiotic strain under the license of BioGaia for its functional 
food product portfolio, reflecting an outside-in process. These licenses show an exploitation 
collaboration, as the resources and competences are not used for research but for the integration 
into products, and there is no joint development.  
 
Two strategic alliances target the inter-industry segment of functional foods. First, in 2009 
Nestlé joined the Healthy Weight Commitment Foundation, the aim of which is to provide tools 
to help consumers achieve energy balance. Since this consortium of more than forty retailers and 
food and beverages manufacturers delivers a communication platform to consumers, the focus of 
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collaboration is existing knowledge and the type of interdependency is discrete, thus resulting in 
an exploitation collaboration. This alliance is within the food sector. In 2012, a collaborative 
agreement between Nestlé and Chromocell Corporation was established to identify compounds 
with potential taste-giving ingredients. This strategic alliance constitutes an exploration 
collaboration because its aim is to discover new knowledge, and because the relationship 
between the partners is reciprocal. The reciprocal interdependency implies a coupled process 
between the food and the pharmaceutical company.  
 
Four joint ventures focus on the inter-industry segment between the food and pharmaceutical 
sectors. Although the two joint ventures between Nestlé and L’Oréal (Innéov, founded in 2002 
and Galderma, founded in 1981) are between a food and personal care company, the inter-
industry segment between food and pharmaceutics is addressed. First, Innéov has launched a 
wide product range in the area of dietary supplements focusing on nutricosmetic health, for 
example targeting gastrointestinal health with probiotic products. This joint venture is an 
exploration collaboration that focuses on a coupled process across industrial boundaries since 
both companies focus on joint research (new knowledge and reciprocal interdependency). The 
same applies to the second joint venture, namely Galderma, which delivers products for skincare. 
To enter the nutraceutical market, Nestlé’s subsidiary Galderma signed an agreement for the 
acquisitions of certain assets of the Innéov Group, since the joint venture Innéov between 
L’Oréal and Nestlé was terminated in 2014. The third joint venture, called Nutrition Science 
Partners, was established in 2012 between Nestlé and Chi-med, a pharmaceutical company 
focusing on traditional Chinese medicine, to develop products for gastrointestinal health, as well 
as for metabolic disorders and brain health in the future. Due to the joint development across 
industrial borders, this joint venture follows the motivation of an exploration collaboration with a 
coupled process. Finally, the fourth joint venture is within the food industry between General 
Mills and Nestlé: the Cereal Partners Worldwide. From 2014, this joint venture expanded its 
product portfolio to gluten-free corn flakes, thus targeting the functional food market. Due to 
joint research and consecutive launches, the joint venture shows an exploration collaboration 
form within the food sector.  
 
Four joint ventures focus on the inter-industry segment between the food and pharmaceutical 
sectors. Although the two joint ventures between Nestlé and L’Oréal (Innéov, founded in 2002 
and Galderma, founded in 1981) are between a food and personal care company, the inter-
industry segment between food and pharmaceutics is addressed. First, Innéov has launched a 
wide product range in the area of dietary supplements focusing on nutricosmetic health, for 
example targeting gastrointestinal health with probiotic products. This joint venture is an 
exploration collaboration that focuses on a coupled process across industrial boundaries since 
both companies focus on joint research (new knowledge and reciprocal interdependency). The 
same applies to the second joint venture, namely Galderma, which delivers products for skincare. 
To enter the nutraceutical market, Nestlé’s subsidiary Galderma signed an agreement for the 
acquisitions of certain assets of the Innéov Group, since the joint venture Innéov between 
L’Oréal and Nestlé was terminated in 2014. The third joint venture, called Nutrition Science 
Partners, was established in 2012 between Nestlé and Chi-med, a pharmaceutical company 
focusing on traditional Chinese medicine, to develop products for gastrointestinal health, as well 
as for metabolic disorders and brain health in the future. Due to the joint development across 
industrial borders, this joint venture follows the motivation of an exploration collaboration with a 
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coupled process. Finally, the fourth joint venture is within the food industry between General 
Mills and Nestlé: the Cereal Partners Worldwide. From 2014, this joint venture expanded its 
product portfolio to gluten-free corn flakes, thus targeting the functional food market. Due to 
joint research and consecutive launches, the joint venture shows an exploration collaboration 
form within the food sector.  
 
Altogether, nineteen acquisitions of pharmaceutically based companies can be identified in the 
last ten years; they all show an outside-in process due to Nestlé’s integration of resources and 
competences from the pharmaceutical sector. Especially starting in 2009, the activity in 
acquisitions seems to have increased. In general, these acquisitions aim to improve the research 
of the formerly distinct companies, thus focusing on new knowledge based on reciprocal 
relationships (exploration collaboration). Three acquisitions by Nestlé of food companies also 
focus on the arisen inter-industry segment due to the integration of resources and competences in 
order to develop functional foods, thus showing an exploration collaboration process. Since 
Nestlé also sells divisions to pharmaceutical companies (nine transactions), Nestlé shows inside-
out processes that focus on the externalization of internal assets, resulting in research activities 
using these resources and competences (exploration collaboration).  
 
Case 2. Danone 
 
Danone was founded in 1919 and strengthened its position through several mergers and 
acquisitions leading to today’s Groupe Danone S.A., which has a leading position in dairy and 
water products worldwide and operates in more than 140 countries. Its SIC categorization 
includes the food sector (codes beginning with 20) as well as the assignment of pharmaceutical 
preparations (SIC 2834), which shows Danone’s orientation towards the health sector. Danone’s 
product portfolio encompasses dairy products and in particular probiotic products that deliver an 
additional health benefit beyond their nutritional value. As market leader in the probiotic sector, 
Danone shows its strength in borderline products rising between food and pharmaceutics. Their 
probiotic products are in the form of traditional food products, thus showing a small distance 
from the traditional food sector in contrast with more specialised products such as formula 
nutrition in the area of medical nutrition. However, concurrently Danone is also active in the 
medical nutrition area and delivers nutritional formulas for patients suffering from distinct 
diseases.  
 
Chronological Development 
 
Overall, Danone’s activity in cross-industry collaborations focusing on the pharmaceutical sector 
is lower than that of Nestlé (ref. Figure 3).  
 
Maphar Laboratories manufacture dietetic products under the licence of Danone. Thus, Danone 
shows an inside-out process towards the pharmaceutical sector. While the resources and 
competences are not integrated into the research process, the form of the collaboration is 
exploitation.  
 
The strategic alliance between Danone and Eurofins encompasses on the one hand the 
acquisition of several of Danone’s laboratories, and on the other hand an exclusive supplier 
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contract for all infant nutrition analyzes, thus reflecting a coupled process between the industry 
sectors. The focus of the collaboration is on already existing knowledge, and the relationship is 
discrete because for the different areas the companies stay separate. Thus, this collaboration is in 
the form of an exploitation.  
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Figure 3. Chronological development of Danone's cross-industry collaborations focusing on the 
inter-industry segment of functional foods in the last ten years. 
 
In 2005, a joint venture between the two food companies Danone and Yakult was formed to 
manufacture and launch probiotic products, thus functional foods. This joint venture shows the 
characteristics of an exploitation collaboration, as the aim is to use the existing knowledge to 
gather advantages in selling the products. In 2008, a joint venture between Danone and Weight 
Watchers International was formed in order to establish a weight management business in China 
focusing on dietary changes to improve health. The two companies stem from the food sector. 
Since this joint venture delivers a communication platform, the focus of the collaboration is on 
existing knowledge and the type of interdependency is discrete, thus resulting in an exploitation 
collaboration.  
 
Three acquisitions of pharmaceutical companies in 2010 and 2011 focus on the inter-industry 
segment of functional foods, acquiring expertise especially in the area of nutritional supplements 
and showing an outside-in process by Danone. The motivation of collaboration is exploration 
due to the incorporation of external resources and competences. On the other hand, Danone 
makes use of an inside-out process focusing on the externalization of internal assets, which 
results in research activities using these resources and competences (exploration collaboration) 
while selling a division to a pharmaceutical company. In addition, three acquisitions of food 
companies by Danone focus on the inter-industry segment of functional foods while the 
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motivation of these collaborations is exploration due to their incorporation of external resources 
and competences.  
 
Cross-Industry Collaborations in the Pharmaceutical Sector 
 
Case 3. Bayer HealthCare 
 
Bayer Healthcare is a subsidiary of Bayer AG, which was founded in 1863. While the roots of 
the company lie in the chemical sector, its first pharmaceutical product was launched in 1880. 
Bayer HealthCare became an independent legal entity in 2003. Today, Bayer HealthCare focuses 
on the development and manufacturing of health care products for humans and animals. Based 
on the SIC categorization, Bayer HealthCare belongs to the pharmaceutical sector (SIC 2834). 
Bayer HealthCare’s product portfolio mainly focuses on over-the-counter (OTC) drugs. 
Nevertheless, Bayer HealthCare launches also consumer products focusing on the inter-industry 
segment between the food and pharmaceutical sectors; for example, in 1940 it launched the first 
multivitamin supplement in the US market. Today its brand ‘One A Day®’ in particular 
addresses the growing market segment of nutritional supplements. 
 
Chronological Development 
 
Although Bayer Healthcare has strong collaborations within its sector encompassing several 
research agreements with universities as well as research centres, its cross-industry joint ventures 
and strategic alliances are only oriented towards the technical part of the health care sector and 
do not focus on the food market.  
 
Bayer HealthCare’s cross-industry activities in the food sector are confined to a single 
acquisition in 2012. With this acquisition, Bayer HealthCare internalised the expertise of 
manufacturing nutritional supplements of Schiff Nutrition International, thus showing an 
outside-in process. The motivation of collaboration is exploration due to the incorporation of 
external resources and competences. 
 
Case 4. Martek Biosciences Corporation 
 
Founded in 1985, Martek Biosciences Corporation (henceforth referred to as ‘Martek’) is a 
subsidiary of Royal DSM and has a market presence in over 49 countries through its parent 
company. Based on the categorization of the SIC, Martek belongs to the pharmaceutical sector 
because its SIC codes begin with 283, indicating ‘drugs’. Martek’s development focuses on 
nutritional oils from microalgae and fungi, which are used in regular foods and beverages as well 
as in specialised nutrition such as infant formula, and pregnancy and nursing products. The 
products are sold directly as well as through distributors, since Martek is a main ingredient 
supplier. The company’s product portfolio focuses on omega-3-fatty acids, since Martek is the 
major supplier of docosahexaenoic acid (DHA) used in infant formula in the US. From a global 
perspective, its products are used in about 75% of infant formulas. The ingredients are marketed 
as brands in the B2B sector. Regarding the level of complementarity, the described product 
portfolio is directly linked to the pharmaceutical sector. At first glance, Martek keeps its products 
in its traditional sector. Reviewing the licensed consumer products, however, the main usage of 
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the ingredients developed and produced by Martek lies in the fortification of food products 
mainly implemented by the food sector. Furthermore, dietary supplements and prescription 
supplements are developed through the supply and licensing agreements between Martek and 
pharmaceutical or food companies. With regard to the level of complementarity, the application 
of the ingredients in food products leading to functional (fortified) foods and dietary supplements 
shows a large distance.  
 
Chronological Development 
 
Overall, cross-industry collaborations in which the involved partners stem from different 
industrial backgrounds can be shown. Martek shows a strong position in licensing its developed 
ingredients for the food sector using the strong consumer and market competences of that sector 
to launch its products. Although Martek is not involved in joint ventures with the food sector, 
strategic alliances with companies from the food sector can be shown in their early phases.   
 
 
 
 
 
 
Figure 4. Chronological development of Martek's cross-industry collaborations focusing on the  
inter-industry segment of functional foods in the last ten years. 
 
Overall, Martek is a strong licensor of omega-3-fatty acids, as the company is the major 
ingredient supplier of DHA for infant formula. In all identified licensing agreements Martek is in 
the licensor position. The food sector is the dominant licensee of ingredients from Martek, thus 
making use of an inside-out process. The motivation of these collaborations lies in the usage of 
existing knowledge (exploitation). Martek also licenses its ingredients to two pharmaceutical 
companies that focus on the functional nutrition market while delivering fortified baby nutrition. 
Again, the motivation of these licensing agreements is the usage of existing knowledge 
(exploitation).  
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In 2008, a collaborative agreement between Dow AgroSciences and Martek was formed to 
jointly develop and commercialise a canola seed that produces DHA. The DHA-rich canola oil is 
aimed at the food industry, thus showing a coupled process between the food and pharmaceutical 
sectors. This joint development indicates an exploration collaboration. In 2007, Martek entered 
into an agreement with Advanced BioNutrition Corporation showing activities in the food and 
the pharmaceutical sectors for the exclusive sale of DHA into the animal health market. In 
return, Martek became the licensee for certain technologies by Advanced BioNutrition 
Corporation, thus reflecting a coupled process between the food and pharmaceutical sectors. The 
focus of the collaboration is on already existing knowledge while the relationship is discrete 
since for the different areas the companies remain separate. Thus, this collaboration is in the 
form of an exploitation.  
 
In 2010, Martek acquired Amerifit Brands Inc. from Charterhouse Group Inc. As Amerifit has an 
advanced sales and marketing infrastructure and a proven management team for selling brands’ 
branded consumer health and wellness products, Martek may close possible competence gaps in 
the commercialization of consumer products, using an outside-in process. The internalization of 
these resources and competences to be implemented in the company’s own process shows an 
exploration motivation. 
 
Case Comparison 
 
Nestlé shows the highest intensity in cross-industry collaborations, possibly due to the overall 
company size. As a result, the product portfolio shows a wide range of borderline products such 
as healthcare nutrition. The second food company considered in this study, Danone, shows a 
lower intensity of cross-industry collaborations than Nestlé. Nevertheless, the product portfolio 
including medical nutrition, for example, shows a high degree of convergence between the food 
and pharmaceutical sectors. The overall amount of cross-industry collaborations of the two 
discussed pharmaceutical companies, Bayer HealthCare and Martek, is lower than that of the 
food companies. Bayer HealthCare for instance focuses its research and development within the 
pharmaceutical sector and shows various collaborations with other pharmaceutical companies.  
 
With regard to the different types of collaborations, the incorporation of resources and 
competences of the partnering companies, and thus the level of integration, differs between the 
collaboration forms as discussed in the following. The level of integration is low in licensing 
agreements because resources and competences are incorporated at most only to a limited 
degree, for instance in order to insert a functional ingredient into the already existing product 
(fortification). Strategic alliances also show a low level of integration of the partners, as only 
parts of the distinct resources and competences are used to complete the task, such as for 
instance jointly developing a specific borderline product. In joint ventures on the other hand, the 
used resources and competences of the involved companies merge due to the establishment of a 
new entity, thus resulting in a higher level of integration than in strategic alliances. Finally, in 
acquisitions the resources and the competences of the involved companies completely merge, 
thus showing the highest level of integration of the presented collaboration types. 
With regard to the timely occurrence of different collaboration forms, the considered food 
companies first show activities in collaborations with a higher integration level (for instance 
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acquisitions), followed by collaborations with a lower integration level (for instance licensing 
agreements). This may be due to the distance of complementary competences between the 
different sectors. First, collaborations of higher integration are needed to overcome the distance 
and for joint research. Based on this movement towards each other, in later stages the distance 
can also be overcome by collaborations of a lower degree of integration.  
 
Figure 6 depicts the identified collaborations focusing on the inter-industry segment of functional 
foods according to the two determinants motivation of collaboration and industrial scope of 
collaboration.  
 
 
Figure 5. Portfolio showing the different collaborations focusing on the inter-industry segment 
of functional foods according to the two determinants of motivation and industrial scope of 
collaboration. 
 
The four described collaboration types occur within the same industry sector focusing on the 
emerging inter-industry segments of functional foods, whereas collaboration forms of lower 
integration are more likely to occur in case of exploitation. The exploration seems to require a 
higher level of integration of the involved companies.  
 
The general characteristics of collaborations can also be shown for collaborations across 
industrial borders, which have to overcome a greater distance between complementary 
competences. If the knowledge exchange is unilateral, companies follow an inside-out or an 
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outside-in process. Licensing agreements are used in exploitation collaborations, thus executing 
the already existing knowledge. Nevertheless, these collaborations have to overcome a greater 
knowledge distance in comparison to licensing agreements between companies from the same 
sector. In other words, executing the already existing knowledge requires the competence to 
adapt the knowledge from outside one’s own industry sector into the existing process. 
Acquisitions occur if the collaborations show an exploration motivation, and thus focus on the 
generation of new knowledge. This collaboration form shows a higher integration of resources 
and competences of the involved companies, or industry sectors, as a more intense cooperation is 
needed to generate new knowledge based on a joint development process. Strategic alliances 
dominate the collaboration forms and follow a coupled process to execute already existing 
knowledge (exploitation). The companies involved in strategic alliances seem to integrate 
specific assets into the development process without a higher degree of overall integration, thus 
remaining separate as companies. In contrast, joint ventures, which show a higher level of 
integration due to the establishment of a joint entity, occur in a coupled process focusing on 
exploration. Due to the generation of new knowledge, a more intense cooperation is required as 
the resources and competences of distinct industry sectors indicate a higher level of competence 
complementarity. 
 
Discussion 
 
Cross-industry collaborations arise at the interface of the food and pharmaceutical sectors, and 
the companies identified in the present study seem to cope differently with the upcoming 
challenge of competence gaps. While the selected food companies show multifaceted cross-
industry activities, the selected pharmaceutical companies seem to focus on the core competence 
of their home sector. As a result, the pharmaceutical companies are more active at the front end 
of the value chain, focusing on research and delivering their products to food companies that 
launch the emerging borderline products due to their higher expertise in consumer marketing.  
 
The analysis of cross-industry collaborations of the food and pharmaceutical sectors reveals a 
higher intensity of the companies from the food sector in cross-industry collaborations towards 
the emerging inter-industry segment of functional foods. While the companies of the food sector 
seem to try to internalise the missing research competences, for example with joint ventures 
focusing on collaborative research, the companies of the pharmaceutical sector on the other hand 
seem to overcome their competence gap in consumer marketing strategies by selling the 
respective ingredients to food companies strong in consumer marketing. 
 
Convergence can be assessed using different cross-industry collaboration forms such as strategic 
alliances or joint ventures, especially as with a higher number of competitors—due to the 
involvement of different sectors—higher rates of collaborations appear (Eisenhardt and 
Schoonhoven 1996). The selected companies from the food and pharmaceutical sectors show 
differences in their intensity of using distinct collaboration types. Recent literature emphasises 
that multiple simultaneous collaborations between different companies is an ubiquitous 
phenomenon (Wassmer 2010), while different forms such as strategic alliances or joint ventures 
occur at the same time. Borderline products arise from companies with a high intensity of cross-
industry activities as well as from those showing a lower intensity. However, the food companies 
dominate the launch of borderline products, such as functional foods or dietary supplements, into 
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the consumer market. This supports the classification of the food sector as being market oriented 
(Bröring 2005) in contrast to the research-intensive pharmaceutical sector (Howells, Gagliardi, 
and Malik 2008).  
 
With regard to the occurrence of cross-industry collaboration forms targeting the inter-industry 
segment over time, the case study indicates a series of collaborations showing at first a high level 
of integration towards subsequently lower levels, thus an evolution from high level of integration 
to lower levels. In other words, first acquisitions, second joint ventures, third strategic alliances 
and fourth licensing agreements emerge. Furthermore, acquisitions and ventures are more likely 
to be used for collaborations focusing on exploration while in contrast strategic alliances and 
licensing agreements are more likely to be used for collaborations focusing on exploitation. 
Thus, first exploration followed by exploitation collaborations occur, supporting the results from 
a study in the biotechnology sector (Rothaermel and Deeds 2004). The outcomes of the 
collaborations with different motivations (exploration vs. exploitation) build on each other. In 
other words, based on the exploration collaborations focusing on joint research and development, 
exploitation collaborations to launch products are more likely to occur.  
 
Earlier studies on the comparison of exploitation and exploration collaborations indicate a more 
frequent occurrence of exploitation collaborations, for instance due to lower resource 
requirements (Koza and Lewin 1998; Rothaermel and Deeds 2004). In contrast, the study at hand 
shows a higher amount of exploration (46) than exploitation (35) collaborations. Because a large 
distance between the traditional fields has to be overcome in collaborations in converging 
industries, it seems that first a joint research background must be established based on extensive 
exploration collaborations before exploitation collaborations can be used to execute the 
knowledge generated in exploration collaborations. 
 
Conclusion 
 
The present paper enhances the literature on evaluating convergence to analyze the rapid market 
changes in emerging sectors, such as the area of functional foods. Although recent scientific 
publications cover approaches for measuring convergence focusing on industry segments, the 
study at hand complements these studies while using an approach to scrutinise convergence on a 
company level based on the two determinants of motivation and industrial scope of 
collaboration.  
 
Practical implications arise around the possibility for companies to use this research framework 
with publicly available data to analyze their direct competitive environment. In doing so, based 
on the identified collaborations, the future market fields of competitors can be determined, such 
as the joint venture between Nestlé and Chi-med planning products for gastrointestinal health, 
for example. Furthermore, new competitors from other industry sectors can be identified. In 
addition, possible partners for collaborations in a certain research area as well as the appropriate 
type of cross-industry collaboration can be chosen. 
 
Besides the advantage of availability of the databases used in this study, internal activities that 
are not published are neglected. Although the study at hand may not cover all collaborations, the 
data set may be of a higher objectivity due to the publicly available sources. Further studies 
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could concentrate on a concurrent analysis of using publicly available data and internal 
information, derived for example through expert interviews. Due to the small sample of cases, 
future studies could concentrate on a broader sample and could use examples from other 
industrial areas as well.  
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Appendix A 
 
Table A1. Summary of Used Terminology 
Industrial scope of collaboration 
Outside-in The outside-in process encompasses the integration of resources and 
competences into the development from other industry sectors.  
Inside-out The inside-out process focuses on the externalization of assets towards other 
industry sectors.  
Coupled process The coupled process incorporates both the internalization of external assets 
as well as the externalization of internal assets. 
Motivation of collaboration 
Exploration  Exploration collaborations aim to explore new opportunities focussing on 
longer-term competitive advantage.  
Exploitation Exploitation collaborations aim to execute existing knowledge 
concentrating on short-term commercialization. 
Type of interdependency 
Reciprocal Reciprocal interdependency describes a joint development using resources 
and competences from both partners.   
Discrete Discrete interdependence describes collaborations with decisions made 
independently by the partners.  
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Figure B1. Emerging inter-industry segment between the food and pharmaceutical sectors. 
